NikhilWagleMD

Oncology • Boston, MA

Physician

Join to view full profile

Dr. Wagle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wagle's full profile

Already have an account?

Office
450 Brookline Avenue
Boston, MA 02215

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008 - 2012
Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2008
Harvard Medical SchoolClass of 2005

Certifications & Licensure

MA State Medical License 2008 - 2023
IA State Medical License 1999 - 2018
IL State Medical License 1999 - 2017
NC State Medical License 1998 - 2017

Clinical Trials

Olaparib + Sapacitabine in BRCA Mutant Breast Cancer Start of enrollment: 2018 Oct 01
Active, not recruiting
Phase 1
'ADVANCE' (A Pilot Trial) Start of enrollment: 2019 Mar 21
Active, not recruiting
Phase 1

Publications & Presentations

PubMed

A standing platform for cancer drug development using ctDNA-based evidence of recurrence.
Arielle J Medford, Ariel B Carmeli, Alexandra Ritchie, Nikhil Wagle, Levi Garraway
Nature Reviews. Cancer. 2024-11-01
7 citations
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Horm...
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma Mahtani, Cynthia Ma
Journal of Clinical Oncology. 2024-06-10
Author Correction: Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments.
Michalina Janiszewska, Doris P Tabassum, Zafira Castaño, Simona Cristea, Kimiyo N Yamamoto
Nature Cell Biology. 2024-05-01

Journal Articles

Article KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
Nikhil Wagle, Myles Brown, Rinath Jeselsohn, ScienceDirect

Press Mentions

Breast Cancer: The Diversity of MetastasesNovember 1st, 2024
How a Patient Partnership Is Propelling Cancer ResearchSeptember 14th, 2022
Dana-Farber’s Dr. Nikhil Wagle Is Using Genomics to Predict a Patient’s Response to Breast Cancer TreatmentJuly 19th, 2022
Join now to see all